Interferon beta-1A for relapsing multiple sclerosis.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000628:therapy*
D016899:Interferon-beta; D000068556:Interferon beta-1a